Hey there! Welcome!
Get updated on
stem cell
stem cell
stem cell
Top Picks

calendar
9 Apr, 26
dot
link
ACC 2026
Key sessions on hypertension, presented at the American College of Cardiology (ACC) 2026 conference held in New Orelans, LA from 28th March to 30th March 2026.

calendar
31 Mar, 26
dot
link
SCCM 2026
Key sessions on antibacterials presented during the Society of Critical Care Medicine (SCCM) 2026 Critical Care Congress, held in Chicago from March 22–24, 2026.

calendar
9 Apr, 26
dot
link
Cardiovasc Diabetol.
  • C-reactive protein-triglyceride-glucose index (CTI), calculated as 0.412 × ln(CRP) + ln(TG × FPG/2), was evaluated in 266,049 UK Biobank participants free of CMD at baseline
  • High CTI predicted elevated risks: T2DM (HR 3.60), CHD (HR 1.52), stroke (HR 1.11), first CMD (FCMD; HR 1.86), CMM (HR 2.50), & death (HR 1.25)
  • CTI showed superior predictive value over TyG & CRP & may be valuable as a CMM screening tool.

calendar
9 Apr, 26
dot
link
Endocrinol Diabetes ...
  • In 84,229 adults with diabetes (mean age 58.3 y), reduced A1c time in range strongly predicted mortality
  • Each 20% decrement increased risk (HR 1.30); instrumental variable models confirmed the link (HR 1.28)
  • Mortality was higher in ≥60 y, ≥60% time below range further raised risk (HR 1.35)
  • A1c stability may be critical for outcome prediction in adults with diabetes.

calendar
6 Apr, 26
dot
link
Diabetes Res Clin Pr...
  • Global T1D Index (2025) estimates 9.5M cases worldwide (13% rise from 2021); 1.0M aged 0–14 & 0.8M aged 15–19
  • Incident cases in 2025: 513k (164k aged 0–14, 58k aged 15–19), premature deaths: 174k, with 17.2% due to non diagnosis after clinical onset
  • Life expectancy for a 10 y old varies by country from 6–66 y
  • Projected prevalence by 2040: 14.7M, data lacking in 119 countries, calling for epidemiological studies.

calendar
3 Apr, 26
dot
link
Indian J Vasc Endova...
  • CLTI patients (age 30–70, n=14) were treated with bone marrow‑derived mesenchymal stem cells (BM‑MSCs) implantation (2M cells/kg)
  • Amputation free survival at 2y seen in 92.85%, pain free walking distance improved significantly (p=0.0494), ABI rose by 0.15 (p=0.0005), TcPO₂ increased 20–25 mmHg (p=0.0046), & 78.5% achieved complete ulcer healing (p=0.0014)
  • Therapy was safe, with minor transient adverse effects.